Symposium Session: Role of the Gut Microbiota and Nutritional Implications for IBS, SIBO, & IBD
This is not a webinar or course for purchase- this is a module for credit claiming for our 2018 Spring Symposium attendees and cannot be purchased or taken by non-attendees. These sessions are exclusive to our symposium, however, the topics may be revisited in the future in the form of a webinar or self-study course.
Suggested CDR Learning Codes: 5000, 5110, 5220
Suggested CDR Performance Indicators: 8.3.6, 8.4.4, 9.1.5
Gut disorders are on the rise globally. Emerging science reveals the complex relationship of diet and the gut microbiome in GI disease. Nutrition professionals should understand the role of diet, gut microbial interactions, and symptom management of conditions such as irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), and inflammatory bowel disease (IBD). Overlapping symptomology occurs in IBS, SIBO, and IBD including abdominal pain and distention, gas, bloating, and alteration in bowel habit. In fact, it has been suggested that IBS-like symptoms occur in 57% of patients with quiescent IBD.
This session will discuss the complexity of GI disorders and how food can elicit GI symptoms and potentially contribute to gut dysbiosis (an imbalance in the gut microbial community). Nutritional interventions to improve patient outcomes will be reviewed including the low-FODMAP diet, enteral nutrition for IBD, as well as the potential deleterious role of food additives and the Western diet.
After attending this session, nutrition professionals should be able to:
- Detail how diet may be a trigger or therapy for IBS, SIBO, and IBD via the impact of changes in gut flora and microbial derived metabolites.
- Describe how FODMAPs impact luminal distention via osmotic and fermentative effects.
- Outline a low-FODMAP elimination and reintroduction nutrition protocol.
Kate Scarlata, RDN, LDN, is a Boston-based dietitian with expertise in food intolerances and digestive health.
Kate Scarlata reports the following relevant disclosures: she is a consultant to Fodmap Food Companies. She has certified that no conflict of interest exists for this program. View our disclosure policy.
- 1.00 CDR